Kadestone Capital Corp. announced that it has appointed Dr. Anthony Holler to its board of directors (the "Board"), increasing the size of the Board to six members, effective immediately. Dr. Holler was CEO of ID Biomedical from 1999 until 2005 when the company was sold to GlaxoSmithKline for $1.7 billion. He currently serves as the CEO and Chairman of the Board of Directors for Sunniva Inc. and Chairman of the Board of Perimeter Medical Imaging AI Inc. Previously, Dr. Holler was Chairman of the Board of Directors of CRH Medical from December 2005 to March 2020. Dr. Holler was also Chairman of Corriente Resources Inc.